In patients with necrotising soft tissue infection (NSTI), does the use of intravenous immunoglobulin (IVIG) compared to placebo improve patient reported physical outcomes?
No sig diff.Mult issues (imbal orgms, HBOT, low dose IVIg, 1 dose pre enrol ok)
- Population
- Not recorded
- Intervention
- Not recorded
- Control
- Not recorded
- Primary Outcome
- Not recorded